The polybacterial mucosal vaccine MV130 impairs airway inflammation in a HDM-induced eosinophilic asthma model
A. Sevilla Ortega (Madrid, Spain), A. Angelina Querencias (Madrid, Spain), B. Marcos Ramiro (Madrid, Spain), M. Pérez Diego (Madrid, Spain), L. Conejero Hall (Madrid, Spain), J. Subiza (Madrid, Spain), O. Palomares Gracia (Madrid, Spain)
Source: International Congress 2022 – New insights into asthma immunology: from mouse to man
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Sevilla Ortega (Madrid, Spain), A. Angelina Querencias (Madrid, Spain), B. Marcos Ramiro (Madrid, Spain), M. Pérez Diego (Madrid, Spain), L. Conejero Hall (Madrid, Spain), J. Subiza (Madrid, Spain), O. Palomares Gracia (Madrid, Spain). The polybacterial mucosal vaccine MV130 impairs airway inflammation in a HDM-induced eosinophilic asthma model. 921
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|